Suchergebnisse - "Han, Kwang-Hyub"

PubPharm (33)

21

Consensus recommendations and review by an International Expert Panel on Interventions in Hepatocellular Carcinoma (EPOIHCC)

enthalten in: Liver international : official journal of the International Association for the Study of the Liver | 2013

von Park, J. | Amarapurkar, D. | Chao, Y. | +15

22

Applicability of BCLC stage for prognostic stratification in comparison with other staging systems : single centre experience from long-term clinical outcomes of 1717 treatment-naïve patients with hepatocellular carcinoma

enthalten in: Liver international : official journal of the International Association for the Study of the Liver | 2012

von Kim, B. | Kim, S. | Park, J. | +7

CommentIn: Liver Int. 2012 Aug;32(7):1037-8. - PMID 22747512

23

Sorafenib versus cytotoxic chemotherapy for patients with advanced hepatocellular carcinoma : a retrospective, single-institution study

enthalten in: Investigational new drugs | 2012

von Lee, S. | Yoon, S. | Park, J. | +4

24

Early on-treatment predictions of clinical outcomes using alpha-fetoprotein and des-gamma-carboxy prothrombin responses in patients with advanced hepatocellular carcinoma

enthalten in: Journal of gastroenterology and hepatology | 2012

von Lee, M. | Kim, S. | Kim, D. | +8

25

How to improve treatment outcomes for hepatocellular carcinoma of intermediate and advanced stage

enthalten in: Digestive diseases (Basel, Switzerland) | 2012

von Kim, D. | Han, K.

26

Sorafenib, doesn't it have any competitor in advanced hepatocellular carcinoma?

enthalten in: Journal of gastroenterology and hepatology | 2011

von Kim, D. | Han, K.

CommentOn: J Gastroenterol Hepatol. 2011 Nov;26(11):1612-8. - PMID 21517968

27

Prognostic value of 18F-FDG PET for hepatocellular carcinoma patients treated with sorafenib

enthalten in: Liver international : official journal of the International Association for the Study of the Liver | 2011

von Lee, J. | Park, J. | Kim, D. | +5

28

Issues and controversies of hepatocellular carcinoma-targeted therapy clinical trials in Asia : experts' opinion

enthalten in: Liver international : official journal of the International Association for the Study of the Liver | 2010

von Chen, P. | Furuse, J. | Han, K. | +7

29

Systemic treatment in advanced/metastatic hepatocellular carcinoma in the era of targeted therapy

enthalten in: Journal of gastroenterology and hepatology | 2010

von Han, K. | Park, J.

CommentOn: J Gastroenterol Hepatol. 2010 Jun;25(6):1117-22. - PMID 20074168

30

Efficacy and safety of transarterial chemoembolization in recurrent hepatocellular carcinoma after curative surgical resection

enthalten in: American journal of clinical oncology | 2009

von Choi, J. | Park, J. | Ahn, S. | +9